Recombinant Pseudomonas aeruginosa UPF0060 membrane protein PA14_21660 (PA14_21660)

Introduction to Recombinant Pseudomonas aeruginosa UPF0060 Membrane Protein PA14_21660

PA14_21660 is a recombinant UPF0060 family membrane protein encoded by the PA14_21660 gene in Pseudomonas aeruginosa PA14, a highly virulent clinical isolate. UPF0060 proteins are part of the uncharacterized protein families (UPFs) with conserved membrane-associated domains, though their precise biological roles remain unclear. PA14_21660 is distinct from other PA14-specific virulence factors (e.g., exoU, rhlR) but shares structural and functional similarities with UPF0060 homologs in other Pseudomonas strains, such as PA3275 in PAO1 (UniProt: Q9HYW6) .

2.1. Protein Structure

UPF0060 proteins are membrane-associated, with potential transmembrane domains and hydrophobic regions. While PA14_21660’s exact topology is uncharacterized, studies on related UPF0060 members suggest:

• Membrane localization: Likely embedded in the bacterial outer membrane or periplasmic space.

• Domain organization: May include conserved motifs for protein-protein interactions or substrate binding.

3.1. Strain-Specific Virulence and Genomic Context

PA14 exhibits enhanced virulence compared to PAO1, partly due to pathogenicity islands and regulatory mutations (e.g., ladS) . While PA14_21660 is not a known virulence factor, its presence in PA14 may reflect strain-specific adaptations:

• Genomic conservation: UPF0060 genes are conserved across Pseudomonas strains but lack functional annotation .

• Hypothetical roles: Could modulate membrane permeability or interact with efflux pumps, influencing antibiotic resistance.

3.2. Recombinant Production and Applications

Recombinant PA14_21660 would follow protocols similar to other Pseudomonas membrane proteins:

• Expression: Use E. coli systems with T7 promoters and affinity tags (e.g., His-tag) for purification .

• Purification: SDS-PAGE validation and solubility optimization, as demonstrated for OmpF and T7-tagged proteins .

• Applications: Structural studies via circular dichroism (CD) or cryo-EM, or use as a vaccine antigen in outer-membrane vesicle (OMV) formulations .

Critical Gaps and Future Directions

PA14_21660 remains understudied, with no published functional or structural data. Key priorities include:

• Functional assays: Testing for porin activity, efflux pump interactions, or biofilm modulation.

• Comparative genomics: Aligning PA14_21660 with UPF0060 homologs to identify conserved motifs.

• High-throughput screening: Leveraging CRISPR-Cas9 or transposon mutagenesis to assess virulence contributions .